The health care company Aetna mailed envelopes that revealed the HIV status of some of its customers in multiple states, according to the Legal Action Center and the AIDS Law Project of Pennsylvania.

The ideal HIV vaccine would elicit humoral responses effective against a broad spectrum of primary HIV strains but immunogens capable of generating such antibodies in humans have been difficult to ...

A major reason for the elusiveness of an HIV vaccine -- despite a number of promising candidates -- is the virus's ability to rapidly mutate or otherwise conceal its outer coat proteins, known as the ...

Since HIV’s discovery in the 1980s, scientists have come a long way in understanding the different steps required for its assembly and maturation. Researchers knew, for instance, that HIV wraps its ...

HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B ...

During the late phase of HIV type 1 (HIV-1) infection cycle, the virally encoded Gag polyproteins are targeted to the inner leaflet of the plasma membrane (PM) for assembly, formation of immature ...